BetaEntity Annotation Prototype
← Back to diseases

Annotated abstract

Implementing a point-of-care test for β-human chorionic gonadotropin testing within an abortion service

familyplanning · 2026-07-10 · canonical JSON source

1 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

There are several scenarios within abortion care in which the measurement of serum beta-human chorionic gonadotropin (β-hCG) levels is useful or necessary. These include the management of pregnancy of unknown location, diagnosis of miscarriage or gestational trophoblastic disease, and confirmation that a medical abortion is complete as part of the protocol for very early medical abortion (VEMA). 1–4